FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885222854> ?p ?o ?g. }

• W2885222854 endingPage "2806" @default.
• W2885222854 startingPage "2799" @default.
• W2885222854 abstract "Cardiac transthyretin (ATTR) amyloidosis is an increasingly recognized, progressive, and fatal cardiomyopathy, the natural history of which remains unclear. We sought to establish and validate a new prognostic staging system applicable to patients with both wild-type ATTR (ATTRwt) and hereditary variant ATTR (ATTRv) amyloid cardiomyopathy. Eight hundred and sixty-nine patients with cardiac ATTR amyloidosis (553 with ATTRwt and 316 with ATTRv) attending the UK National Amyloidosis Centre were stratified into three disease stages at baseline on the basis of cut points in two universally measured biomarkers, N-terminal pro-B-type natriuretic peptide (NT-proBNP) and estimated glomerular filtration rate (eGFR). Stage I was defined as NT-proBNP ≤3000 ng/L and eGFR ≥45 ml/min, Stage III was defined as NT-proBNP >3000 ng/L and eGFR <45 ml/min, and the remainder were Stage II. The staging system was validated in a cohort of 318 patients with cardiac ATTR amyloidosis from France. Median survival among 393 (45%) Stage I patients was 69.2 months, 334 (38%) Stage II patients was 46.7 months, and 142 (16%) Stage III patients was 24.1 months (P < 0.0001). After adjusting for age, compared with Stage I, the hazard ratio (HR) for death for Stage II was 2.05 [confidence interval (CI) 1.54–2.72, P < 0.001] and for Stage III was 3.80 (CI 2.73–5.28, P < 0.001). HRs and statistical significance were little altered by transthyretin genotype and were maintained in the validation cohort. This simple, universally applicable staging system stratifies patients with both ATTRwt and ATTRv amyloid cardiomyopathy into prognostic categories. It will be of value in the design of forthcoming clinical trials of novel amyloid-specific therapies." @default.
• W2885222854 created "2018-08-22" @default.
• W2885222854 creator A5005309087 @default.
• W2885222854 creator A5007011827 @default.
• W2885222854 creator A5026745347 @default.
• W2885222854 creator A5033490022 @default.
• W2885222854 creator A5035970044 @default.
• W2885222854 creator A5050123012 @default.
• W2885222854 creator A5050125018 @default.
• W2885222854 creator A5052162807 @default.
• W2885222854 creator A5057365396 @default.
• W2885222854 creator A5061607833 @default.
• W2885222854 creator A5061857871 @default.
• W2885222854 creator A5070623406 @default.
• W2885222854 creator A5072732766 @default.
• W2885222854 creator A5081406713 @default.
• W2885222854 creator A5090961709 @default.
• W2885222854 date "2017-10-18" @default.
• W2885222854 modified "2023-10-18" @default.
• W2885222854 title "A new staging system for cardiac transthyretin amyloidosis" @default.
• W2885222854 cites W1120283132 @default.
• W2885222854 cites W1769623626 @default.
• W2885222854 cites W1986782676 @default.
• W2885222854 cites W2033060908 @default.
• W2885222854 cites W2050904540 @default.
• W2885222854 cites W2053960009 @default.
• W2885222854 cites W2061527271 @default.
• W2885222854 cites W2080718344 @default.
• W2885222854 cites W2107403553 @default.
• W2885222854 cites W2115656635 @default.
• W2885222854 cites W2131999691 @default.
• W2885222854 cites W2133199265 @default.
• W2885222854 cites W2148373528 @default.
• W2885222854 cites W2151289840 @default.
• W2885222854 cites W2169727724 @default.
• W2885222854 cites W2227889351 @default.
• W2885222854 cites W2282508430 @default.
• W2885222854 cites W2314304229 @default.
• W2885222854 cites W2337532627 @default.
• W2885222854 cites W2509971241 @default.
• W2885222854 cites W2584609294 @default.
• W2885222854 cites W2586517468 @default.
• W2885222854 cites W2606797430 @default.
• W2885222854 cites W4210576276 @default.
• W2885222854 doi "https://doi.org/10.1093/eurheartj/ehx589" @default.
• W2885222854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29048471" @default.
• W2885222854 hasPublicationYear "2017" @default.
• W2885222854 type Work @default.
• W2885222854 sameAs 2885222854 @default.
• W2885222854 citedByCount "351" @default.
• W2885222854 countsByYear W28852228542017 @default.
• W2885222854 countsByYear W28852228542018 @default.
• W2885222854 countsByYear W28852228542019 @default.
• W2885222854 countsByYear W28852228542020 @default.
• W2885222854 countsByYear W28852228542021 @default.
• W2885222854 countsByYear W28852228542022 @default.
• W2885222854 countsByYear W28852228542023 @default.
• W2885222854 crossrefType "journal-article" @default.
• W2885222854 hasAuthorship W2885222854A5005309087 @default.
• W2885222854 hasAuthorship W2885222854A5007011827 @default.
• W2885222854 hasAuthorship W2885222854A5026745347 @default.
• W2885222854 hasAuthorship W2885222854A5033490022 @default.
• W2885222854 hasAuthorship W2885222854A5035970044 @default.
• W2885222854 hasAuthorship W2885222854A5050123012 @default.
• W2885222854 hasAuthorship W2885222854A5050125018 @default.
• W2885222854 hasAuthorship W2885222854A5052162807 @default.
• W2885222854 hasAuthorship W2885222854A5057365396 @default.
• W2885222854 hasAuthorship W2885222854A5061607833 @default.
• W2885222854 hasAuthorship W2885222854A5061857871 @default.
• W2885222854 hasAuthorship W2885222854A5070623406 @default.
• W2885222854 hasAuthorship W2885222854A5072732766 @default.
• W2885222854 hasAuthorship W2885222854A5081406713 @default.
• W2885222854 hasAuthorship W2885222854A5090961709 @default.
• W2885222854 hasBestOaLocation W28852228541 @default.
• W2885222854 hasConcept C121157162 @default.
• W2885222854 hasConcept C126322002 @default.
• W2885222854 hasConcept C146357865 @default.
• W2885222854 hasConcept C151730666 @default.
• W2885222854 hasConcept C159641895 @default.
• W2885222854 hasConcept C164705383 @default.
• W2885222854 hasConcept C207103383 @default.
• W2885222854 hasConcept C2775915353 @default.
• W2885222854 hasConcept C2777607188 @default.
• W2885222854 hasConcept C2778198053 @default.
• W2885222854 hasConcept C2778797674 @default.
• W2885222854 hasConcept C2779951007 @default.
• W2885222854 hasConcept C2779962030 @default.
• W2885222854 hasConcept C44249647 @default.
• W2885222854 hasConcept C71924100 @default.
• W2885222854 hasConcept C72563966 @default.
• W2885222854 hasConcept C86803240 @default.
• W2885222854 hasConcept C90924648 @default.
• W2885222854 hasConceptScore W2885222854C121157162 @default.
• W2885222854 hasConceptScore W2885222854C126322002 @default.
• W2885222854 hasConceptScore W2885222854C146357865 @default.
• W2885222854 hasConceptScore W2885222854C151730666 @default.
• W2885222854 hasConceptScore W2885222854C159641895 @default.
• W2885222854 hasConceptScore W2885222854C164705383 @default.

• next